v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Total revenue $ 1,629 $ 1,777 $ 3,625 $ 3,232
Costs and expenses:        
Cost of revenue 218 515 613 1,021
Research and development 18,066 11,449 33,723 23,033
General and administrative 6,048 5,386 12,791 11,525
Licensing 1,235 1,335 2,628 2,345
Revaluation of contingent consideration 300 1,500 300 1,800
Total costs and expenses 25,867 20,185 50,055 39,724
Loss from operations (24,238) (18,408) (46,430) (36,492)
Other income:        
Interest income 1,761 2,018 3,275 4,184
Non-cash royalty income 972 961 1,826 1,794
Total other income 2,733 2,979 5,101 5,978
Net loss $ (21,505) $ (15,429) $ (41,329) $ (30,514)
Net loss per share, basic $ (0.15) $ (0.13) $ (0.3) $ (0.25)
Net loss per share, diluted $ (0.15) $ (0.13) $ (0.3) $ (0.25)
Weighted average common shares outstanding, basic 142,736,848 122,580,967 135,811,921 122,486,162
Weighted average common shares outstanding, diluted 142,736,848 122,580,967 135,811,921 122,486,162
Other comprehensive (loss) income:        
Unrealized (loss) gain on marketable securities, net of tax of $0 $ (326) $ 48 $ (914) $ 385
Total other comprehensive (loss) income (326) 48 (914) 385
Comprehensive loss (21,831) (15,381) (42,243) (30,129)
Contract research        
Revenues:        
Total revenue 356 442 893 887
Licensing        
Revenues:        
Total revenue $ 1,273 $ 1,335 $ 2,732 $ 2,345